Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-19-001703
Filing Date
2019-05-23
Accepted
2019-05-23 09:39:21
Documents
40
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT FOR XBRL dougherty_10qa1-033119.htm 10-Q/A 29498
  Complete submission text file 0001683168-19-001703.txt   1541098

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE mydp-20190331.xml EX-101.INS 265366
3 XBRL SCHEMA FILE mydp-20190331.xsd EX-101.SCH 19391
4 XBRL CALCULATION FILE mydp-20190331_cal.xml EX-101.CAL 41949
5 XBRL DEFINITION FILE mydp-20190331_def.xml EX-101.DEF 64969
6 XBRL LABEL FILE mydp-20190331_lab.xml EX-101.LAB 171747
7 XBRL PRESENTATION FILE mydp-20190331_pre.xml EX-101.PRE 137539
Mailing Address 5924 ROYAL LANE, SUITE 250 DALLAS TX 75230
Business Address 5924 ROYAL LANE, SUITE 250 DALLAS TX 75230 972-250-0945
Dougherty's Pharmacy, Inc. (Filer) CIK: 0001080029 (see all company filings)

EIN.: 752900905 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-27945 | Film No.: 19848182
SIC: 5912 Retail-Drug Stores and Proprietary Stores